Literature DB >> 7654192

Binding of blood coagulation factor VIII and its light chain to phosphatidylserine/phosphatidylcholine bilayers as measured by ellipsometry.

J Spaargaren1, P L Giesen, M P Janssen, J Voorberg, G M Willems, J A van Mourik.   

Abstract

Factor VIII is a plasma protein which plays an essential role in the coagulation system. When assembled with the enzyme Factor IXa on a phospholipid membrane, it functions as a cofactor in the enzyme complex that cleaves the zymogen Factor X to Factor Xa. We studied the binding of both Factor VIII and the Factor VIII light chain to planar phospholipid bilayers consisting of 25% dioleoylphosphatidylserine and 75% dioleoylphosphatidylcholine (PSPC) by ellipsometry. Equilibrium-binding studies revealed that both Factor VIII and its light chain bind with high affinity to PSPC bilayers. The binding affinity of Factor VIII, with a dissociation constant Kd of 0.24 nM, was comparable with that of the Factor VIII light chain (Kd 0.49 nM). Maximal binding was 2.3 mmol of protein per mol of PSPC for Factor VIII and 7.1 mmol of protein per mol of PSPC for the Factor VIII light chain. Adsorption kinetics of both Factor VIII and its light chain conformed to the classical Langmuir adsorption model yielding dissociation constants calculated from the rates of adsorption that were similar to those obtained by equilibrium-binding studies. In contrast, measurements of rates of desorption revealed a deviation from those expected for a single class of binding sites. The desorption rate of Factor VIII increased with increasing residence time on the lipid membrane. This indicates transition of Factor VIII to a configuration with a lower binding affinity. As this time-dependent change in affinity could affect the validity of the measurement of binding parameters, in particular equilibrium-binding determinations carried out on a long timescale, binding affinity was also estimated from adsorption kinetics at half-maximal surface coverage, a relatively rapid procedure for the determination of the affinity. A Kd of 0.087 nM was obtained under these conditions. Measurement of equilibrium binding to small PSPC vesicles, a system in which equilibrium is rapidly attained, resulted in similar binding parameters (Kd = 0.13 nM and a maximal binding of 2.8 mmol of protein per mol of PSPC). These data confirm the results of equilibrium binding to planar bilayers. Taken together, our results indicate that Factor VIII, by means of its 80 kDa light chain, binds to PSPC bilayers with a dissociation constant below the concentration of Factor VIII in plasma and therefore may readily bind to exposed phospholipid membranes under physiological conditions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7654192      PMCID: PMC1135928          DOI: 10.1042/bj3100539

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  36 in total

1.  Isolation and characterization of human factor VIII: molecular forms in commercial factor VIII concentrate, cryoprecipitate, and plasma.

Authors:  L O Andersson; N Forsman; K Huang; K Larsen; A Lundin; B Pavlu; H Sandberg; K Sewerin; J Smart
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

2.  Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity.

Authors:  D Eaton; H Rodriguez; G A Vehar
Journal:  Biochemistry       Date:  1986-01-28       Impact factor: 3.162

3.  Membrane binding kinetics of factor VIII indicate a complex binding process.

Authors:  C Bardelle; B Furie; B C Furie; G E Gilbert
Journal:  J Biol Chem       Date:  1993-04-25       Impact factor: 5.157

4.  Structure of human factor VIII.

Authors:  G A Vehar; B Keyt; D Eaton; H Rodriguez; D P O'Brien; F Rotblat; H Oppermann; R Keck; W I Wood; R N Harkins; E G Tuddenham; R M Lawn; D J Capon
Journal:  Nature       Date:  1984 Nov 22-28       Impact factor: 49.962

5.  Molecular cloning of a cDNA encoding human antihaemophilic factor.

Authors:  J J Toole; J L Knopf; J M Wozney; L A Sultzman; J L Buecker; D D Pittman; R J Kaufman; E Brown; C Shoemaker; E C Orr
Journal:  Nature       Date:  1984 Nov 22-28       Impact factor: 49.962

6.  Application of sepharose-linked monoclonal antibodies for the immunoradiometric measurement of factor VIII-procoagulant antigen.

Authors:  E C Veerman; H V Stel; J G Huisman; J A van Mourik
Journal:  Thromb Res       Date:  1984-01-01       Impact factor: 3.944

7.  Differential scanning calorimetry and 31P NMR studies on sonicated and unsonicated phosphatidylcholine liposomes.

Authors:  B de Kruijff; P R Cullis; G K Radda
Journal:  Biochim Biophys Acta       Date:  1975-09-16

8.  Characterization of recombinant human factor VIII.

Authors:  D L Eaton; P E Hass; L Riddle; J Mather; M Wiebe; T Gregory; G A Vehar
Journal:  J Biol Chem       Date:  1987-03-05       Impact factor: 5.157

9.  The adsorption of prothrombin to phosphatidylserine multilayers quantitated by ellipsometry.

Authors:  P A Cuypers; J W Corsel; M P Janssen; J M Kop; W T Hermens; H C Hemker
Journal:  J Biol Chem       Date:  1983-02-25       Impact factor: 5.157

10.  The adsorption of prothrombin to phospholipid monolayers quantitated by ellipsometry.

Authors:  J M Kop; P A Cuypers; T Lindhout; H C Hemker; W T Hermens
Journal:  J Biol Chem       Date:  1984-11-25       Impact factor: 5.157

View more
  7 in total

1.  Effects of excluded surface area and adsorbate clustering on surface adsorption of proteins. II. Kinetic models.

Authors:  A P Minton
Journal:  Biophys J       Date:  2001-04       Impact factor: 4.033

2.  Dissimilar interaction of factor VIII with endothelial cells and lipid vesicles during factor X activation.

Authors:  H J Brinkman; P Koster; K Mertens; J A van Mourik
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

3.  A mathematical model of coagulation under flow identifies factor V as a modifier of thrombin generation in hemophilia A.

Authors:  Kathryn G Link; Michael T Stobb; Matthew G Sorrells; Maria Bortot; Katherine Ruegg; Marilyn J Manco-Johnson; Jorge A Di Paola; Suzanne S Sindi; Aaron L Fogelson; Karin Leiderman; Keith B Neeves
Journal:  J Thromb Haemost       Date:  2019-11-01       Impact factor: 5.824

4.  Synergy Between Tissue Factor and Exogenous Factor XIa in Initiating Coagulation.

Authors:  Karin Leiderman; William C Chang; Mikhail Ovanesov; Aaron L Fogelson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-10-27       Impact factor: 8.311

5.  Kinetics of Factor X activation by the membrane-bound complex of Factor IXa and Factor VIIIa.

Authors:  Mikhail A Panteleev; Evgueni L Saenko; Natalya M Ananyeva; Fazoil I Ataullakhanov
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

Review 6.  Haemophilia.

Authors:  Erik Berntorp; Kathelijn Fischer; Daniel P Hart; Maria Elisa Mancuso; David Stephensen; Amy D Shapiro; Victor Blanchette
Journal:  Nat Rev Dis Primers       Date:  2021-06-24       Impact factor: 52.329

7.  A factor VIIIa-mimetic bispecific antibody, Mim8, ameliorates bleeding upon severe vascular challenge in hemophilia A mice.

Authors:  Henrik Østergaard; Jacob Lund; Per J Greisen; Stine Kjellev; Anette Henriksen; Nikolai Lorenzen; Eva Johansson; Gustav Røder; Morten G Rasch; Laust B Johnsen; Thomas Egebjerg; Søren Lund; Henrik Rahbek-Nielsen; Prafull S Gandhi; Kasper Lamberth; Mette Loftager; Lisbeth M Andersen; Amalie C Bonde; Fabian Stavenuiter; Daniel E Madsen; Xun Li; Thomas L Holm; Carsten D Ley; Peter Thygesen; Haisun Zhu; Rong Zhou; Karina Thorn; Zhiru Yang; Mette B Hermit; Jais R Bjelke; Bjarne G Hansen; Ida Hilden
Journal:  Blood       Date:  2021-10-07       Impact factor: 22.113

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.